Mesoblast MPCs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesoblast MPCs, covering 2020-03-11 to 2020-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure [Phase 2]